MedTrace Logo

Is Family Screening Improved by Genetic Testing of Familial Hypercholesterolemia

NCT04526457 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2020-12-10

No results posted yet for this study

Summary

To test the hypothesis that in patients with a clinical diagnosis of familial hypercholesterolemia (FH), genetic testing and identification of a causative mutation might enhance the success of family-based cascade screening.

Conditions

  • Hypercholesterolemia, Familial

Interventions

OTHER

Standard of Care

Randomized to standard of care with lipid testing only.

OTHER

Genetic Testing

Randomized to genetic testing.

Sponsors & Collaborators

Principal Investigators

  • Daniel J Rader, MD · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-01
Primary Completion
2016-12-01
Completion
2017-04-01

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04526457 on ClinicalTrials.gov